S Hallock
Overview
Explore the profile of S Hallock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
20
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weerasinghe P, Hallock S, Tang S, Liepins A
Cell Biol Toxicol
. 2002 Jan;
17(6):371-81.
PMID: 11787859
Sanguinarine, a benzophenanthridine alkaloid, has anticancer potential through induction of cell death. We previously demonstrated that sanguinarine treatment at a low level induced apoptosis or programmed cell death (PCD) in...
2.
Weerasinghe P, Hallock S, Tang S, Liepins A
Pathol Res Pract
. 2002 Jan;
197(11):717-26.
PMID: 11770015
Our previous studies with low Bcl-2-expressing K562 cells have shown that, when treated with the putative anti-cancer drug sanguinarine, concentrations of 1.5 microg/ml induced the morphology of apoptosis or programmed...
3.
Weerasinghe P, Hallock S, Liepins A
Exp Mol Pathol
. 2001 Aug;
71(1):89-98.
PMID: 11502101
The apoptosis related proteins Bax, Bcl-2, and NF-kappaB were analyzed in sanguinarine induced apoptosis and blister cell death (BCD) of K562 erythroleukemia cells and in sanguinarine treated high Bcl-2 expressing...